Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by InMed Pharmaceuticals Inc.

InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Submits Form 12b-25
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Provides Business Update and Milestones for 2023
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Announces Results of 2022 Annual General Meeting
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Provides Update on Management Changes
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week
From InMed Pharmaceuticals Inc.
Via GlobeNewswire
Tickers INM
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.